In:
Arthritis Care & Research, Wiley, Vol. 76, No. 4 ( 2024-04), p. 444-453
Abstract:
The objective was to understand how the expansion of rheumatology supply and the introduction of multidisciplinary care was associated with access to rheumatology services. Methods We accessed Population Data BC, a longitudinal database with de‐identified individual‐level health data on all residents of British Columbia, Canada, to analyze physician visits and prescribing from 2010–2011 to 2019–2020. We calculated access as the time from referral to first rheumatologist visit and, for people with rheumatoid arthritis (RA), time to first disease‐modifying antirheumatic drug (DMARD). Associations between lag time, patient characteristics, and system variables were explored using quantile regression. Results Over the study period, there were 149,902 new rheumatologist visits, with 31% more visits in 2019–2020 than in 2010–2011. The proportion of first visits for patients with inflammatory arthritis increased from 28% to 51%. The median time from referral to first visit decreased by 22 days (35%) from 63 days (interquartile range 21–120 days) in 2010–2011. For people with RA, time from referral to DMARD decreased by 4 days (6%) to 62 days. Male sex, living in metropolitan areas, and having a rheumatologist who used a multidisciplinary care assessment code were associated with shorter times from referral to first DMARD. Conclusion Access to rheumatology care improved, and the increased proportion of patients with IA in the first visits case‐mix indicates that rheumatologist supply and incentives for multidisciplinary care may have improved referral patterns. However, time to DMARDs for people with RA remained long, and we found signals of unequal access for female patients and people living outside of metropolitan areas.
Type of Medium:
Online Resource
ISSN:
2151-464X
,
2151-4658
Language:
English
Publisher:
Wiley
Publication Date:
2024
detail.hit.zdb_id:
2016713-1
Permalink
